Evaluating the effectiveness of a Diabetes Needs Assessment Tool (DNAT): a randomised controlled trial
| ISRCTN | ISRCTN67215088 |
|---|---|
| DOI | https://doi.org/10.1186/ISRCTN67215088 |
| Secondary identifying numbers | N/A |
- Submission date
- 29/01/2009
- Registration date
- 30/01/2009
- Last edited
- 11/01/2018
- Recruitment status
- No longer recruiting
- Overall study status
- Completed
- Condition category
- Nutritional, Metabolic, Endocrine
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Plain English summary of protocol
Not provided at time of registration
Contact information
Dr Dean Jenkins
Scientific
Scientific
Cardiff Medicentre
Heath Park
Cardiff
CF14 4UJ
United Kingdom
| Phone | +44 (0)2920 757744 |
|---|---|
| DJenkins@bmjgroup.com |
Study information
| Study design | Multicentre randomised controlled trial |
|---|---|
| Primary study design | Interventional |
| Secondary study design | Randomised controlled trial |
| Study setting(s) | Other |
| Study type | Treatment |
| Participant information sheet | Not available in web format, please use the contact details below to request a patient information sheet |
| Scientific title | Evaluating the effectiveness of using a Diabetes Needs Assessment Tool (DNAT) on health professionals' knowledge of diabetes and self-reported changes in clinical practice: a randomised controlled trial |
| Study objectives | Amended as of 26/03/2009: Aims: 1. To evaluate the effectiveness of using a new online Diabetes Needs Assessment Tool (DNAT) to improve knowledge of how to manage diabetes 2. To evaluate the acceptability of this format of learning 3. To evaluate self-reported changes in clinical practice as a result of this learning Hypotheses: 1. Four months after being administered the online learning materials, learners in the intervention group will show greater diabetes knowledge and report higher levels of acceptability of the learning materials than learners in the control group 2. Five months after being administered the online learning materials, learners in the intervention group will report more changes to their clinical practice than learners in the control group Initial information at the time of registration: Aims: 1. To evaluate the effectiveness of using a new online Diabetes Needs Assessment Tool (DNAT) to improve knowledge of how to manage diabetes 2. To evaluate the acceptability of this format of learning 3. To evaluate self-reported changes in clinical practice as a result of this learning Hypotheses: 1. Four months after being administered the online learning materials, learners in the intervention group will show greater knowledge change and report higher levels of acceptability of the learning materials than learners in the control group 2. Five months after being administered the online learning materials, learners in the intervention group will report more changes to their clinical practice than learners in the control group |
| Ethics approval(s) | As of 11/02/2009 the REC for Wales has confirmed that the study does not require full ethical review |
| Health condition(s) or problem(s) studied | Diabetes |
| Intervention | Both the control group and the intervention group will be given access to the same online Diabetes Learning Modules during a 4-month learning period. The Diabetes Learning Modules include: 1. Current evidence-based guidelines (particularly those of the European Society of Cardiology and the European Association for the Study of Diabetes [ESC-EASD] Guidelines on Diabetes, Pre-diabetes and Cardiovascular Disease) 2. Important clinical areas and common difficulties in practice 3. Type 1, Type 2, diabetes in pregnancy and secondary causes of diabetes All content of these learning modules is applicable to European practice and material comes from BMJ Learning, Elsevier Health Sciences and the International Diabetes Federation. In addition to the Diabetes Learning Modules, the intervention group will be administered the Diabetes Needs Assessment Tool (DNAT). The DNAT is a computerised adaptive test comprised of clinically rich case problems. On completion of the DNAT, a personalised learning report is created for each learner identifying their learning needs alongside individualised recommendations of the most appropriate Diabetes Learning Modules to meet those needs. At any stage this personalised report can be viewed listing the performance of the learner at that point. |
| Intervention type | Other |
| Primary outcome measure | Amended as of 26/03/2009: Diabetes knowledge as measured by the Diabetes Knowledge Test at four months. Initial information at the time of registration: Change in knowledge scores on the Diabetes Knowledge Test from baseline (randomisation) to 4 months after administration of learning materials. |
| Secondary outcome measures | 1. Acceptability of the learning materials measured by an electronic survey 4 months after being administered the learning materials 2. Self-reported changes in clinical practice measured by an electronic survey 5 months after being administered the learning materials |
| Overall study start date | 06/02/2009 |
| Completion date | 25/09/2009 |
Eligibility
| Participant type(s) | Patient |
|---|---|
| Age group | Adult |
| Sex | Both |
| Target number of participants | 200 |
| Key inclusion criteria | Participants must be either English or German speaking practising doctors or nurses (approximately 20 - 65 years, either sex) managing at least one patient with diabetes a week. |
| Key exclusion criteria | Doctors and nurses not managing at least one patient with diabetes a week. |
| Date of first enrolment | 06/02/2009 |
| Date of final enrolment | 25/09/2009 |
Locations
Countries of recruitment
- Germany
- United Kingdom
- Wales
Study participating centre
Cardiff Medicentre
Cardiff
CF14 4UJ
United Kingdom
CF14 4UJ
United Kingdom
Sponsor information
BMJ Group (UK)
Industry
Industry
c/o Mrs Vanessa Edmonds
BMA House
Tavistock Square
London
WC1H 9JR
United Kingdom
| Phone | +44 (0)20 7383 6567 |
|---|---|
| vedmonds@bmjgroup.com | |
| Website | http://group.bmj.com/ |
"ROR" |
https://ror.org/02caz1f24 |
Funders
Funder type
Industry
Merck Sharp and Dohme Regional Business Support Center (MSD RBSC) GmbH (Germany) - involved in design of study but no access to data or statistical analyses
No information available
BMJ Group (UK) - not involved in statistical analyses
No information available
Results and Publications
| Intention to publish date | |
|---|---|
| Individual participant data (IPD) Intention to share | No |
| IPD sharing plan summary | Not provided at time of registration |
| Publication and dissemination plan | Not provided at time of registration |
| IPD sharing plan |
Study outputs
| Output type | Details | Date created | Date added | Peer reviewed? | Patient-facing? |
|---|---|---|---|---|---|
| Protocol article | protocol | 30/07/2009 | Yes | No | |
| Results article | results | 16/06/2011 | Yes | No |
Editorial Notes
11/01/2018: publication ref added.
